168 related articles for article (PubMed ID: 24521741)
21. Expression and clinicopathologic significance of TUFM and p53 for the normal-adenoma-carcinoma sequence in colorectal epithelia.
Xi HQ; Zhang KC; Li JY; Cui JX; Zhao P; Chen L
World J Surg Oncol; 2017 Apr; 15(1):90. PubMed ID: 28449687
[TBL] [Abstract][Full Text] [Related]
22. Proteins in stool as biomarkers for non-invasive detection of colorectal adenomas with high risk of progression.
Komor MA; Bosch LJ; Coupé VM; Rausch C; Pham TV; Piersma SR; Mongera S; Mulder CJ; Dekker E; Kuipers EJ; van de Wiel MA; Carvalho B; Fijneman RJ; Jimenez CR; Meijer GA; de Wit M
J Pathol; 2020 Mar; 250(3):288-298. PubMed ID: 31784980
[TBL] [Abstract][Full Text] [Related]
23. Differential expression of p53 family proteins in colorectal adenomas and carcinomas: Prognostic and predictive values.
Bahnassy AA; Zekri AR; Salem SE; Abou-Bakr AA; Sakr MA; Abdel-Samiaa AG; Al-Bradei M
Histol Histopathol; 2014 Feb; 29(2):207-16. PubMed ID: 23996743
[TBL] [Abstract][Full Text] [Related]
24. The tumor suppressor NPRL2 in hepatocellular carcinoma plays an important role in progression and can be served as an independent prognostic factor.
Otani S; Takeda S; Yamada S; Sakakima Y; Sugimoto H; Nomoto S; Kasuya H; Kanazumi N; Nagasaka T; Nakao A
J Surg Oncol; 2009 Oct; 100(5):358-63. PubMed ID: 19274676
[TBL] [Abstract][Full Text] [Related]
25. Expression of NDRG2 is down-regulated in high-risk adenomas and colorectal carcinoma.
Lorentzen A; Vogel LK; Lewinsky RH; Saebø M; Skjelbred CF; Godiksen S; Hoff G; Tveit KM; Lothe IM; Ikdahl T; Kure EH; Mitchelmore C
BMC Cancer; 2007 Oct; 7():192. PubMed ID: 17935612
[TBL] [Abstract][Full Text] [Related]
26. Aberrant expression of m
Kuai D; Zhu S; Shi H; Yang R; Liu T; Liu H; Min L; Zhang S
Life Sci; 2021 May; 273():119258. PubMed ID: 33636176
[TBL] [Abstract][Full Text] [Related]
27. Detection of methylated septin 9 in tissue and plasma of colorectal patients with neoplasia and the relationship to the amount of circulating cell-free DNA.
Tóth K; Wasserkort R; Sipos F; Kalmár A; Wichmann B; Leiszter K; Valcz G; Juhász M; Miheller P; Patai ÁV; Tulassay Z; Molnár B
PLoS One; 2014; 9(12):e115415. PubMed ID: 25526039
[TBL] [Abstract][Full Text] [Related]
28. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
[TBL] [Abstract][Full Text] [Related]
29. MicroRNAs in blood act as biomarkers of colorectal cancer and indicate potential therapeutic targets.
Stang A; Weilert H; Lipp MJ; Oldhafer KJ; Hoheisel JD; Zhang C; Bauer AS
Mol Oncol; 2021 Sep; 15(9):2480-2490. PubMed ID: 34288395
[TBL] [Abstract][Full Text] [Related]
30. REG IV overexpression in an early stage of colorectal carcinogenesis: an immunohistochemical study.
Li XH; Zheng Y; Zheng HC; Takahashi H; Yang XH; Masuda S; Takano Y
Histol Histopathol; 2010 Apr; 25(4):473-84. PubMed ID: 20183800
[TBL] [Abstract][Full Text] [Related]
31. Discovery and validation of molecular biomarkers for colorectal adenomas and cancer with application to blood testing.
LaPointe LC; Pedersen SK; Dunne R; Brown GS; Pimlott L; Gaur S; McEvoy A; Thomas M; Wattchow D; Molloy PL; Young GP
PLoS One; 2012; 7(1):e29059. PubMed ID: 22276102
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic Potential of Cell-Free and Exosomal MicroRNAs in the Identification of Patients with High-Risk Colorectal Adenomas.
Uratani R; Toiyama Y; Kitajima T; Kawamura M; Hiro J; Kobayashi M; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Goel A; Kusunoki M
PLoS One; 2016; 11(10):e0160722. PubMed ID: 27760147
[TBL] [Abstract][Full Text] [Related]
33. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M
Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702
[TBL] [Abstract][Full Text] [Related]
34. Differential Expression of HER2 and SKP2 in Benign and Malignant Colorectal Lesions.
Moussa M; Badawy A; Helal N; Hegab F; Youssef M; Aboushousha T; Al Faruok L; Elwy D
Asian Pac J Cancer Prev; 2020 Aug; 21(8):2357-2366. PubMed ID: 32856866
[TBL] [Abstract][Full Text] [Related]
35. Genome-wide expression profiling in colorectal cancer focusing on lncRNAs in the adenoma-carcinoma transition.
Kalmár A; Nagy ZB; Galamb O; Csabai I; Bodor A; Wichmann B; Valcz G; Barták BK; Tulassay Z; Igaz P; Molnár B
BMC Cancer; 2019 Nov; 19(1):1059. PubMed ID: 31694571
[TBL] [Abstract][Full Text] [Related]
36. Comparison of Circulating miRNAs Expression Alterations in Matched Tissue and Plasma Samples During Colorectal Cancer Progression.
Nagy ZB; Barták BK; Kalmár A; Galamb O; Wichmann B; Dank M; Igaz P; Tulassay Z; Molnár B
Pathol Oncol Res; 2019 Jan; 25(1):97-105. PubMed ID: 28980150
[TBL] [Abstract][Full Text] [Related]
37. Decreased fragile histidine triad expression in colorectal cancer and its association with apoptosis inhibition.
Cao J; Chen XP; Li WL; Xia J; Du H; Tang WB; Wang H; Chen XW; Xiao HQ; Li YY
World J Gastroenterol; 2007 Feb; 13(7):1018-26. PubMed ID: 17373735
[TBL] [Abstract][Full Text] [Related]
38. High expression of testes-specific protease 50 is associated with poor prognosis in colorectal carcinoma.
Zheng L; Xie G; Duan G; Yan X; Li Q
PLoS One; 2011; 6(7):e22203. PubMed ID: 21765952
[TBL] [Abstract][Full Text] [Related]
39. Identification of an intermediate signature that marks the initial phases of the colorectal adenoma-carcinoma transition.
Tang H; Guo Q; Zhang C; Zhu J; Yang H; Zou YL; Yan Y; Hong D; Sou T; Yan XM
Int J Mol Med; 2010 Nov; 26(5):631-41. PubMed ID: 20878084
[TBL] [Abstract][Full Text] [Related]
40. The ratio of Matriptase/HAI-1 mRNA is higher in colorectal cancer adenomas and carcinomas than corresponding tissue from control individuals.
Vogel LK; Saebø M; Skjelbred CF; Abell K; Pedersen ED; Vogel U; Kure EH
BMC Cancer; 2006 Jul; 6():176. PubMed ID: 16820046
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]